#transplant — Public Fediverse posts

#MASLD in kidney transplant recipients #KTR is associated with worse patient and graft survival

https://www.kireports.org/article/S2468-0249(26)02709-9/fulltext?rss=yes

#transplant #medicine #nephrology

I thought that the fantastical price tag might be keeping some patients from getting #Zynteglo

Turns out, that doesn't seem to be the case (yet), as I detail in a sister piece about Bluebird and the #insurance logistics behind these therapies:

https://www.statnews.com/2023/12/08/lyfgenia-sickle-cell-gene-therapy-bluebird-vertex-crispr-casgevy/

#health #healthcare #scd #crispr #betathalassemia #transplant #lyfgenia #casgevy #healthinsurance #pharma #bigpharma #biotech